Today, July 21st, marks the 3rd Annual Glioblastoma (GBM) Awareness Day. Brains for the Cure invites you to join us, Head for the Cure, and the entire brain tumor community on honoring this important day!

History of GBM Awareness Day: National Brain Tumor Society (NBTS) advocated for the bipartisan Senate Resolution 245, designating July 17, 2019, as the first “Glioblastoma Awareness Day.” Introduced by U.S. Senator Lindsey Graham (R-SC), with the support of co-sponsors Senate Majority Leader Mitch McConnell (R-KY), Senators Elizabeth Warren (D-MA), Kyrsten Sinema (D-AZ), Martha McSally (R-AZ), and Ed Markey (D-MA), S.Res. 245 will raise public awareness for glioblastoma (GBM), the most common and aggressive form of brain cancer, and leverage support for research, treatment development, patients, and their families. Head for the Cure Foundation and dozens of other brain tumor organizations were excited to endorse this resolution.

You can support vital clinical research needed to find more treatment options, and a cure, with a donation to the Head for the Cure Foundation. While supporting research and clinical trials, you’re also helping fund important support resources for patients, survivors, and caregivers like Brains for the Cure.

Learn how you can make an impact on GBM Awareness Day!

FAQs About Glioblastoma

  • Glioblastoma is the most common, complex, treatment-resistant, and deadliest type of brain cancer.
  • Approximately 13,000 Americans will receive a glioblastoma diagnosis in 2021.
  • The five-year survival rate for glioblastoma patients is only 7.2% and the median length of survival is only 8 months.
  • Brain tumors, including glioblastoma, represent the highest per-patient initial cost of care for any cancer group, with an annualized mean net cost of care approaching $150,000.
  • It is estimated that more than 10,000 Americans will succumb to glioblastoma every year.
  • Despite first being identified in scientific literature in the 1920s, there are only four FDA approved drugs and one device to treat glioblastoma.